Similar Articles |
|
Bio-IT World May 7, 2002 Malorye Branca |
In Silico Survivors Facing desperate times, bioinformatics companies revamp, refocus, or perish. |
Bio-IT World October 14, 2004 Salvatore Salamone |
Riding the New Wave New offerings from Accelrys, LION bioscience, MDL, Synthematix, and Tripos may be the crest of a new wave of software designed to meet increasing demand to incorporate chemoinformatics into the drug discovery process. |
Bio-IT World November 12, 2002 James Golden |
The Business of Bioinformatics The industry has reached an interesting crossroads. As an academic branch of learning, bioinformatics remains mostly what it always was, a cross-disciplinary endeavor between computer science and molecular biology. But bioinformatics as a money-making proposition has different criteria for success. |
CIO October 15, 2001 Stephanie Overby |
Drug Companies on speed The marriage of IT and medical research may be just what traditional pharmaceutical companies need to survive in an increasingly competitive field. Learn how IT is bringing the pharmaceutical industry into the information age... |
Bio-IT World March 8, 2005 Kevin Davies |
InforSense Approach to Data Sharing CEO Yike Guo discusses Shanghai's giant grid computing project to link scientists. |
Bio-IT World July 11, 2002 Mike Fitzgerald |
Funding the Future Investor G. Steven Burrill, CEO of Burrill & Company, helps biotech companies fulfill their potential. He talked recently about his view of the bio-IT field. |
Bio-IT World March 10, 2003 Mark D. Uehling |
Technology Overload Inundated with new IT tools and mountains of data, the pharmaceutical industry struggles to pull it all together. |
Bio-IT World October 9, 2002 John Dodge |
Dell's Simple Formula for Life Sciences Coming off a gangbuster third quarter that yielded a $50-million profit versus a $101-million loss a year ago, Dell Computer Corp. is finally starting to talk publicly about the life sciences. |
InternetNews February 24, 2006 Clint Boulton |
Steve Mills, Senior Vice President, IBM Software IBM's software Senior Vice President Steve Mills discusses the company's information management strategy. |
Industrial Physicist Jennifer Ouellette |
Bioinformatics moves into the mainstream An explosion of data is being tamed with new systems |
Bio-IT World August 13, 2003 Branca et al. |
Discovery Surges and Tools Deliver Market Compass for Q2 finds consolidation among drug discovery companies continuing, but market caps rising. |
Bio-IT World January 13, 2003 Kari Stefansson |
The Icelandic Man Cometh The founder of deCODE Genetics on Viking DNA, privacy, disease, and aging. |
Bio-IT World February 18, 2004 |
Correspondence One of the Top Three Worst Ideas... Bioinformatics: Reasons to Believe... |
Bio-IT World November 2005 |
Bridges and Boundaries in Drug Discovery Research Good communication, blurring cultural boundaries, and strong project governance may be as, if not more, important as sweeping technology solutions when it comes to converging discovery and IT and expediting drug development. |
Bio-IT World March 10, 2003 Michael Greeley |
Too Much Informatics Did bioinformatics companies forget about the fundamental law of supply and demand? |
Bio-IT World June 12, 2002 John Dodge |
All Systems Go at ISB The Seattle-based Institute for Systems Biology (ISB), takes a holistic view of genomic and proteomic research. The author spoke with its president, noted biologist Leroy Hood, recently to find out how far ISB has come in its two years of life. |
Bio-IT World November 19, 2004 Kevin Davies |
The Book on Bioinformatics Research director David Mount talks about his new book "Bioinformatics: Sequence and Genome Analysis," sequence analysis, and teaching bioinformatics |
Bio-IT World December 10, 2002 |
Craig Venter Unvarnished (part II) The former Celera CEO covers privacy, ESTs, and his new research institutes. |
Bio-IT World March 8, 2005 John Russell |
Debating Business Models for Bioinformatics Companies Nailing down a single formula for successfully selling bioinformatics products or services has proven elusive. Harvard Business School tackles informatics' basic question: Where's the money? |
Bio-IT World June 12, 2002 Beth Schachter |
Informatics Moves to the Head of the Class The race is on to increase the quantity and quality of bio-IT training programs as government and academia bet the need will be great. Will the job market back up that bet? |
InternetNews November 19, 2004 Clint Boulton |
Halsey Minor, CEO Grand Central Communications The entrepreneur discusses his latest venture, which proposes to integrate customers' applications on demand. |
Information Today April 2004 Paula Hane |
EBSCO Celebrates Its 60th Anniversary If you haven't noticed, EBSCO is no longer just a journal-subscription company. |
Bio-IT World April 2007 Christopher Frenz |
The Case for Security in Bioinformatics Should developers or distributors of bioinformatics applications be required to make security considerations an essential element of their development or hosting process? While there have been no reports of widespread abuse of scientific computing resources to date, the potential does exist. |